Pharmaron Beijing Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Cash & Equivalents	1,017	1,690	5,919	1,497	3,544
Short-Term Investments	885.65	257.27	179.36	613.24	1,080
Trading Asset Securities	736.62	1,120	621.98	745.36	1,555
Cash & Short-Term Investments	2,640	3,068	6,720	2,856	6,178
Cash Growth	-13.94%	-54.35%	135.30%	-53.77%	60.37%
Accounts Receivable	3,188	2,871	2,636	2,214	1,424
Other Receivables	58.2	126.89	80.98	71.16	92.43
Receivables	3,246	2,998	2,717	2,286	1,516
Inventory	1,472	1,117	1,013	1,041	680.04
Other Current Assets	420.16	425.67	423.68	352.82	269.05
Total Current Assets	7,778	7,608	10,874	6,536	8,644
Property, Plant & Equipment	11,970	10,798	10,062	8,464	5,811
Long-Term Investments	1,158	883.04	1,005	1,008	762.67
Goodwill	3,586	2,761	2,781	2,688	2,096
Other Intangible Assets	1,197	791	789.06	802.53	692.94
Long-Term Deferred Tax Assets	262.91	192.68	153.22	58.79	15.6
Long-Term Deferred Charges	617.99	678.5	520.47	496.38	171.6
Other Long-Term Assets	465.28	155.44	267.09	438.91	195.99
Total Assets	27,094	23,927	26,477	20,493	18,389
Accounts Payable	606.59	477.09	412.22	406.35	315.53
Accrued Expenses	1,050	853.93	805.65	784.92	626.21
Short-Term Debt	1,265	764.97	577.07	662.77	421.76
Current Portion of Long-Term Debt	3,501	282.34	150.34	74.94	60.54
Current Portion of Leases	122.7	149.51	185.32	164.03	95.29
Current Income Taxes Payable	133.2	160.08	184.55	145.87	81.34
Current Unearned Revenue	960.61	834.86	740.87	832.14	679.62
Other Current Liabilities	724.9	701.23	598.47	841.4	701.7
Total Current Liabilities	8,364	4,224	3,654	3,912	2,982
Long-Term Debt	1,772	4,377	8,200	4,454	4,423
Long-Term Leases	379.42	401.31	585.2	760.51	284.34
Long-Term Unearned Revenue	442.86	409.98	391.71	152.38	149.44
Long-Term Deferred Tax Liabilities	397.15	291.87	290.04	261.01	173.3
Other Long-Term Liabilities	-	-	117.58	112.09	81.56
Total Liabilities	11,355	9,705	13,239	9,653	8,094
Common Stock	1,779	1,778	1,787	1,191	794.18
Additional Paid-In Capital	4,950	5,008	5,222	5,254	6,008
Retained Earnings	8,568	7,257	5,818	4,574	3,554
Treasury Stock	-304.89	-416.27	-463.45	-668.04	-301.83
Comprehensive Income & Other	71.8	-7.76	193.72	197.26	74.15
Total Common Equity	15,064	13,619	12,557	10,549	10,129
Minority Interest	674.38	603.54	681.25	291.25	166.07
Shareholders' Equity	15,739	14,223	13,238	10,840	10,295
Total Liabilities & Equity	27,094	23,927	26,477	20,493	18,389
Total Debt	7,040	5,975	9,698	6,117	5,285
Net Cash (Debt)	-4,401	-2,908	-2,977	-3,260	893.04
Net Cash Growth	-	-	-	-	-68.12%
Net Cash Per Share	-2.48	-1.64	-1.68	-1.84	0.49
Filing Date Shares Outstanding	1,830	1,766	1,787	1,787	1,787
Total Common Shares Outstanding	1,771	1,766	1,787	1,787	1,787
Working Capital	-585.84	3,384	7,220	2,624	5,662
Book Value Per Share	8.51	7.71	7.03	5.90	5.67
Tangible Book Value	10,282	10,068	8,987	7,058	7,340
Tangible Book Value Per Share	5.81	5.70	5.03	3.95	4.11
Buildings	5,647	4,921	3,971	3,347	2,473
Machinery	7,595	6,274	5,149	4,265	2,919
Construction In Progress	2,365	2,254	2,633	1,671	1,374

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.